|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89.5 CHF | -0.56% |
|
+4.64% | +5.46% |
| Apr. 26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
| Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Jan 19 (Reuters) - GlaxoSmithKline PLC:
* GSK AND NOVARTIS ANNOUNCE COLLABORATION TO SUPPORT SCIENTIFIC RESEARCH INTO GENETIC DIVERSITY IN AFRICA
* GSK - PROJECT AFRICA GENOMIC RESEARCH APPROACH FOR DIVERSITY AND OPTIMISING THERAPEUTICS WITH COMBINED FUNDING COMMITMENT OF GBP 2.8M OVER 5 YEARS Source text for Eikon: Further company coverage:
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 1,653 GBX | +0.76% | +3.38% | 83.75B | ||
| 462 PTS | +1.81% | +1.69% | - | ||
| 157.6 PTS | +3.21% | +3.26% | - | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +5.46% | 201B | |
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| -9.61% | 193B | |
| -6.26% | 144B | |
| -11.77% | 143B |
NOVARTIS AG 
